Axxess Pharma, Inc. Partners With Nutritional Products International (NPI) To Distribute Full Line Of TapouT Products Across The United States

TORONTO, ON--(Marketwired - January 23, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly-owned subsidiary AllStar Health Brands Inc. and Nutritional Products International (NPI) are pleased to announce their partnership to distribute across the United States, Axxess Pharma’s full line of TapouT Pain Relief and Vitamins & Supplements, including its new Extreme Muscle Growth and Recovery line.

Mitch Gould, CEO of NPI, has relationships with every major online retailer, sports nutrition, and food, drug & mass outlets. These include but are not limited to: Amazon.com, GNC, Vitamin Shoppe, Wal-Mart, CVS and Walgreens. He has more than 25 years of experience in the retail industry, with expertise spanning several categories of consumer products, including: sports nutrition brands, dietary supplements, nutraceuticals and beverages.

“To have Mitch Gould and the NPI team handle the US distribution for us allows our Research and Development team to thrive, leaving our sales and marketing to NPI,” stated Axxess Pharma President, Daniel Bagi, M.D. “NPI’s three generations of distribution experience speaks volumes about their abilities, and their turnkey system has been exactly what we’ve been looking for. We know that our product line is in the right hands with Mitch and the NPI team.”

TapouT Extreme Muscle Growth, a product under development for the past six months, is a powerful new supplement that combines the best natural ingredients for today’s active men. TapouT Muscle Recovery is a revolutionary approach to intense training and rapid pain relief. Originally developed with fighters in mind; the first product, TapouT Muscle Recovery debuted on the “Ultimate Fighter” TV program in 2011 and instantly gained popularity with the contestants... the word quickly spread to athletes in every sport.

“Having worked with the some of the biggest celebrities and athletes in the world, such as Chuck Liddell, Ronnie Colemen, Steven Seagal, and Hulk Hogan, I’m so excited to celebrate this newest project, TapouT Muscle Recovery Line,” says Mitch Gould, CEO of Nutritional Products International. “The TapouT brand is prestigious, trusted and sought after by almost every MMA/UFC athlete and many others for their clothing and fitness lines. We’re excited to now make their pain relief and supplement line a household name as well.”

To learn more about TapouT Muscle Recovery products, please visit: www.tapoutmusclerecovery.com

About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess’s goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements.

About Nutritional Products International (NPI): Headquartered in Boca Raton, FL, Nutritional Products International (NPI) is a privately held company staffed with a complementary team of marketing professionals that specializes in retail distribution of Nutraceuticals, Dietary Supplements, Functional Beverages, and Skin Care Products. NPI offers a unique proven approach for product manufacturers world-wide seeking to launch or expand distribution of their products in the U.S. retail market. For more information, visit www.nutricompany.com.

Safe Harbor Statement

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.